↓ Skip to main content

Circadian Regulator CLOCK Drives Immunosuppression in GlioblastomaCLOCK in GBM immunosuppression

Overview of attention for article published in Cancer Immunology Research, April 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter
42 X users
facebook
1 Facebook page

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Circadian Regulator CLOCK Drives Immunosuppression in GlioblastomaCLOCK in GBM immunosuppression
Published in
Cancer Immunology Research, April 2022
DOI 10.1158/2326-6066.cir-21-0559
Pubmed ID
Authors

Wenjing Xuan, Wen-Hao Hsu, Fatima Khan, Madeline Dunterman, Lizhi Pang, Derek A. Wainwright, Atique U. Ahmed, Amy B. Heimberger, Maciej S. Lesniak, Peiwen Chen

X Demographics

X Demographics

The data shown below were collected from the profiles of 42 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 17%
Other 2 11%
Student > Doctoral Student 2 11%
Student > Ph. D. Student 2 11%
Student > Master 2 11%
Other 1 6%
Unknown 6 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 39%
Nursing and Health Professions 1 6%
Sports and Recreations 1 6%
Medicine and Dentistry 1 6%
Unknown 8 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2023.
All research outputs
#1,498,411
of 24,965,047 outputs
Outputs from Cancer Immunology Research
#148
of 1,500 outputs
Outputs of similar age
#34,846
of 435,633 outputs
Outputs of similar age from Cancer Immunology Research
#6
of 41 outputs
Altmetric has tracked 24,965,047 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,500 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.1. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,633 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.